High levels of IB6 are often found in NSCLC, making it a good target for treatment. A preclinical study found that in lung cancer, IB6 was correlated with interleukin-8 levels and promoted cancer cell ...
A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...
After spending 20 years at Novartis, Radiopharm Theranostics Ltd. CEO Riccardo Canevari told BioWorld that when he joined Radiopharm he wanted to focus on something different within ...
Protein evolution occurs slowly via small incremental mutations—usually. However, dramatic changes can happen: for instance, a fragment of one protein getting copied into the middle of another. While ...
New research reveals a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis, or ALS, a fatal ...
Cancer cells produce small amounts of their own form of type 1 collagen (Col1), creating a unique extracellular matrix that affects the tumor microbiome and protects against immune responses, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback